The Rise of Telehealth and Hims
Telehealth services have surged in popularity, offering unprecedented convenience for accessing medical care. In 2021, over one-third of American adults utilized telemedicine services [1.7.1]. Hims is a prominent direct-to-consumer (DTC) telehealth company that has capitalized on this trend, focusing on men's health issues like erectile dysfunction (ED), hair loss (androgenetic alopecia), and mental health [1.2.2].
The platform operates on a simple model: patients complete an online questionnaire, a licensed medical provider reviews their information, and if appropriate, a prescription is issued and shipped directly to the patient [1.5.1]. This process is designed to be discreet and remove the potential discomfort of in-person consultations for sensitive conditions [1.2.2]. While Hims employs board-certified doctors licensed to practice in the states they serve, the safety of this model hinges on several critical factors, including patient honesty, the limitations of remote diagnosis, and the nature of the medications themselves [1.2.2, 1.5.1].
Medications, Pharmacology, and Safety
Hims primarily offers well-established, FDA-approved medications. The safety of these drugs is well-documented through extensive clinical research [1.2.2].
For Erectile Dysfunction (ED):
- Sildenafil (generic Viagra), Tadalafil (generic Cialis), Vardenafil, and Avanafil (Stendra): These are phosphodiesterase-5 (PDE5) inhibitors [1.2.2]. They work by increasing blood flow to the penis following sexual stimulation. By inhibiting the PDE5 enzyme, they allow cyclic guanosine monophosphate (cGMP) to accumulate, which relaxes smooth muscles and widens blood vessels [1.2.2].
- Common Side Effects: Headache, facial flushing, nasal congestion, indigestion, and muscle pain are common [1.2.2]. A significant risk involves their effect on blood pressure; they can cause dangerous drops in blood pressure, especially when taken with nitrates or by individuals with pre-existing cardiovascular conditions. Hims requires users to submit a recent blood pressure reading before a prescription is approved [1.2.2].
For Hair Loss:
- Finasteride: This oral medication is FDA-approved to treat male pattern baldness [1.2.4]. It works by blocking the enzyme 5-alpha-reductase, which converts testosterone to dihydrotestosterone (DHT), a hormone that shrinks hair follicles [1.2.4].
- Minoxidil: A topical treatment (also the active ingredient in Rogaine) that is also FDA-approved [1.2.1]. Its exact mechanism is not fully understood, but it's believed to be a vasodilator that may improve follicle function and stimulate hair growth.
- Side Effects and Warnings: While generally considered safe, finasteride carries risks. In April 2025, the FDA issued a warning about topical finasteride after reports of side effects including depression, dizziness, and low libido [1.2.3]. Hims has described the side effects of its topical version as "minimal," which highlights a point of contention regarding patient awareness and informed consent in a telehealth setting [1.2.3]. Common side effects of minoxidil include scalp irritation and unwanted facial hair growth [1.2.1].
Regulatory Scrutiny and Compounded Medications
A key area of concern involves compounded medications. These are custom-formulated drugs mixed by a pharmacy, which are not themselves FDA-approved, even if their active ingredients are [1.2.2]. Hims has heavily marketed compounded products, such as chewable ED medications and multi-ingredient topical formulas [1.4.2].
In September 2025, the FDA sent a warning letter to Hims & Hers, stating the company made "false or misleading claims" about its compounded semaglutide products (the active ingredient in Ozempic and Wegovy) [1.9.5, 1.9.2]. The FDA noted that Hims' marketing implied its products were the same as the FDA-approved brand-name drugs when they are not [1.4.4, 1.9.3]. This regulatory action underscores the risks associated with compounded drugs, which may have issues with purity or potency [1.4.3]. The Better Business Bureau (BBB) profile for Hims & Hers Inc. shows an A+ rating but also includes complaints related to billing and cancellation issues [1.8.5, 1.8.2].
Comparison: Hims vs. Roman vs. Traditional Care
The telehealth landscape includes several key players, with Roman being a primary competitor to Hims. Both operate on a similar DTC model, connecting patients with licensed physicians for a limited set of conditions [1.5.1, 1.5.2].
Feature | Hims | Roman | Traditional In-Person Care |
---|---|---|---|
Convenience | High: Asynchronous online consults, direct shipping [1.2.2]. | High: Similar online model, fast shipping [1.5.5]. | Low: Requires scheduling, travel, and pharmacy visits. |
Cost | Generally lower for generic drugs compared to traditional care; offers multiple billing cycles [1.2.2]. Often slightly cheaper than Roman [1.5.3]. | Transparent pricing but often slightly higher than Hims for many products [1.5.3]. | Varies widely based on insurance coverage; can be higher for uninsured patients. |
Scope of Care | Limited to specific conditions (ED, hair loss, mental health, etc.) [1.2.2]. | Also limited to a specific set of conditions, similar to Hims [1.5.4]. | Comprehensive: Full physical exams, diagnostic testing, management of complex conditions. |
Physician Relationship | Transactional; communication is typically through a messaging portal [1.2.2]. | Similar to Hims, with a focus on messaging-based communication [1.5.5]. | Continuous; allows for a long-term relationship and holistic health overview [1.2.3]. |
Privacy | HIPAA-compliant for medical data, but uses website tracking for marketing like other retail sites [1.2.2, 1.6.2]. | HIPAA-compliant; similar use of web tracking data [1.5.5, 1.6.2]. | High, governed strictly by HIPAA in a controlled environment. |
Conclusion
So, is Hims actually safe? The answer is nuanced. The platform provides access to legitimate, FDA-approved medications prescribed by licensed doctors for specific, well-defined conditions [1.2.2, 1.5.1]. For many men, it represents a convenient, private, and effective way to receive treatment [1.2.2].
The primary risks do not stem from the medications themselves—which are the same drugs prescribed in traditional settings—but from the telehealth model's limitations. Safety relies heavily on the patient's ability to provide a complete and accurate medical history without a physical examination. Furthermore, recent FDA actions against Hims for its marketing of compounded drugs highlight a significant concern [1.9.1]. Patients may not fully understand that these formulations are not FDA-approved and may carry different risks [1.4.4]. While Hims is a legitimate medical provider, patients must be proactive, read all information carefully, and understand that for complex health issues, nothing replaces a comprehensive, in-person consultation with a primary care physician.
Authoritative Link: Telehealth Privacy and Security Tips for Patients from HHS.gov [1.6.4]